Literature DB >> 22311412

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

Hui Dong1, Fu-Er Lu, Li Zhao.   

Abstract

Chinese herbal medicine has developed new therapies for nonalcoholic fatty liver disease (NAFLD) based on its unique theory system and substantial herb remedies. In this review, 21 traditional Chinese herbs were introduced for their potential benefit in the treatment of NAFLD. Majority of them are evaluated by experimental studies and few by multicenter clinical trials. Herbal monomers as berberine and resveratrol, extracts from Polygonum hypoleucum Ohwi, and Artemisia sacrorum Ledeb., and formulae including Yinchenhao Decoction (, YCHD), Qushi Huayu Decoction (, QSHYD), and Danning Tablet () were discussed in detail on their therapeutic potentials. Most of these herbal medicines were proved to improve biochemical and histological changes of NAFLD both in vitro and in vivo. Also, their therapeutic activities were associated with inhibiting lipid accumulation through adenosine monophosphate-activated protein kinase activation or upregulating low-density lipoprotein receptor (LDLR) expression, alleviating lipid peroxidation, and reducing the production of inflammatory cytokines. Although the efficacy and safety of these herbal medicines needed to be evaluated in multicenter large-scale clinical trials, Chinese medicine is promising and effective for preventing and treating NAFLD disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311412     DOI: 10.1007/s11655-012-0993-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  61 in total

1.  Effect of Xuezhikang Capsule on serum tumor necrosis factor-alpha and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia.

Authors:  Xiao-fen Fan; Yin-quan Deng; Lei Ye; You-di Li; Jiu Chen; Wen-wen Lu; Jian-ping Li
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

2.  Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats.

Authors:  XinXia Chang; HongMei Yan; Jing Fei; MingHong Jiang; HongGuang Zhu; DaRu Lu; Xin Gao
Journal:  J Lipid Res       Date:  2010-06-21       Impact factor: 5.922

3.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Authors:  Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

4.  Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.

Authors:  Yanwen Wang; Tony Campbell; Benjamin Perry; Cécile Beaurepaire; Ling Qin
Journal:  Metabolism       Date:  2010-03-20       Impact factor: 8.694

Review 5.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.

Authors:  D Grahame Hardie
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

6.  Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease.

Authors:  Nan Wang; Hui Dong; Shichao Wei; Fuer Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

7.  Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease: a multicenter clinical trial.

Authors:  Jian-Gao Fan
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-08

8.  Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways.

Authors:  Peiyong Zheng; Guang Ji; Zansong Ma; Tao Liu; Lianjun Xin; Hongzhong Wu; Xin Liang; Jianwen Liu
Journal:  Am J Chin Med       Date:  2009       Impact factor: 4.667

9.  SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.

Authors:  Xiuyun Hou; Shanqin Xu; Karlene A Maitland-Toolan; Kaori Sato; Bingbing Jiang; Yasuo Ido; Fan Lan; Kenneth Walsh; Michel Wierzbicki; Tony J Verbeuren; Richard A Cohen; Mengwei Zang
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

10.  [Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponectin-free fatty acid pathway].

Authors:  Hong-Shan Li; Qin Feng; Li-Li Xu; Shao-Dong Chen; Xue-Mei Li; Yi-Yang Hu
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-06
View more
  22 in total

1.  Regulation of growth performance and lipid metabolism in juvenile grass carp (Ctenopharyngodon idella) with honeysuckle (Lonicera japonica) extract.

Authors:  Xiao-Lin Meng; Zhen-Xiang Zhu; Rong-Hua Lu; Shuai Li; Wen-Pan Hu; Chao-Bin Qin; Xiao Yan; Guo-Kun Yang; Guo-Xing Nie
Journal:  Fish Physiol Biochem       Date:  2019-05-18       Impact factor: 2.794

Review 2.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

3.  Protective effects of calycosin against CCl4-induced liver injury with activation of FXR and STAT3 in mice.

Authors:  Xinli Chen; Qiang Meng; Changyuan Wang; Qi Liu; Huijun Sun; Xiaokui Huo; Pengyuan Sun; Xiaobo Yang; Jinyong Peng; Kexin Liu
Journal:  Pharm Res       Date:  2014-08-21       Impact factor: 4.200

4.  Icaritin ameliorates carbon tetrachloride-induced acute liver injury mainly because of the antioxidative function through estrogen-like effects.

Authors:  Peng Liu; Xiang Jin; Hao Lv; Jing Li; Wen Xu; Hai-hua Qian; Zhengfeng Yin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-23       Impact factor: 2.416

5.  Amelioration of Non-Alcoholic Steatohepatitis by Atractylodes macrocephala Polysaccharide, Chlorogenic Acid, and Geniposide Combination Is Associated With Reducing Endotoxin Gut Leakage.

Authors:  Jing Leng; Hua-Jie Tian; Yi Fang; Yi-Yang Hu; Jing-Hua Peng
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

6.  Etiology Exploration of Non-alcoholic Fatty Liver Disease From Traditional Chinese Medicine Constitution Perspective: A Cross-Sectional Study.

Authors:  Ke Zhu; Yongsong Guo; Chenghao Zhao; Shixin Kang; Jialiang Li; Jiexin Wang; Zhaohui Tang; Bing Lin; Weihong Li
Journal:  Front Public Health       Date:  2021-05-12

Review 7.  Recent advances in the herbal treatment of non-alcoholic Fatty liver disease.

Authors:  Jia Xiao; Kwok Fai So; Emily C Liong; George L Tipoe
Journal:  J Tradit Complement Med       Date:  2013-04

8.  Jiao tai wan attenuates hepatic lipid accumulation in type 2 diabetes mellitus.

Authors:  Zhaoyi Huang; Xiaohu Xu; Fuer Lu; Nan Wang; Guang Chen; Yan Zhao; Xin Zou; Kaifu Wang; Hui Dong; Lijun Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-10       Impact factor: 2.629

9.  Potent effects of dioscin against liver fibrosis.

Authors:  Xiaoling Zhang; Xu Han; Lianhong Yin; Lina Xu; Yan Qi; Youwei Xu; Huijun Sun; Yuan Lin; Kexin Liu; Jinyong Peng
Journal:  Sci Rep       Date:  2015-04-08       Impact factor: 4.379

10.  Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice.

Authors:  Eunhui Seo; Yoon Sin Oh; Hee-Sook Jun
Journal:  Nutrients       Date:  2016-02-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.